open access

Vol 11, Supp. I (2015)
Case report
Published online: 2016-06-16
Get Citation

Fulvestrant endocrine therarapy in patient with CNS dissemination of breast cancer

Łukasz Hajac

open access

Vol 11, Supp. I (2015)
CASE REPORTS
Published online: 2016-06-16

Abstract

With constant improvement of medicine we can diagnose and treat breast cancer in more and more effective way. Unfortunately, due to low level of social knowledge and consciousness about our own health status in our country many women visit physicians too late, when the disease is difficult to cope with. For this and other reasons there is a substantial number of patients that cannot be fully cured. In many of them cancer spreads, sometimes involving brain metastases, which are considered to be one of the most unfavorable risk factors and usually causes death in shorter time perspective than other localization of dissemination. It is often followed by deterioration of patients’ condition and appearance of some kind of neurological deficit. It can further limit possibility of treatment, especially prescribing cytotoxic chemotherapy. Usually well-tolerated endocrine therapy is a valuable option here and it can stabilize disease. This case study is about encoraging effect of fulvestrant treatment as a third-line endocrine therapy in patient with breast cancer with dissemination to central nervous system.

Abstract

With constant improvement of medicine we can diagnose and treat breast cancer in more and more effective way. Unfortunately, due to low level of social knowledge and consciousness about our own health status in our country many women visit physicians too late, when the disease is difficult to cope with. For this and other reasons there is a substantial number of patients that cannot be fully cured. In many of them cancer spreads, sometimes involving brain metastases, which are considered to be one of the most unfavorable risk factors and usually causes death in shorter time perspective than other localization of dissemination. It is often followed by deterioration of patients’ condition and appearance of some kind of neurological deficit. It can further limit possibility of treatment, especially prescribing cytotoxic chemotherapy. Usually well-tolerated endocrine therapy is a valuable option here and it can stabilize disease. This case study is about encoraging effect of fulvestrant treatment as a third-line endocrine therapy in patient with breast cancer with dissemination to central nervous system.

Get Citation

Keywords

breast cancer, brain metastases, fulvestrant

About this article
Title

Fulvestrant endocrine therarapy in patient with CNS dissemination of breast cancer

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. I (2015)

Article type

Case report

Published online

2016-06-16

Keywords

breast cancer
brain metastases
fulvestrant

Authors

Łukasz Hajac

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl